NYSE · Analyst Forecast

Fresenius Medical Care AG & Co. KGaA (FMS) Analyst Forecast

$23.69 NYSE: FMS Market Cap $12.72B

Revenue and earnings estimates published by analysts covering Fresenius Medical Care AG & Co. KGaA (FMS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Fresenius Medical Care AG & Co. KGaA, analysts forecast revenue rising from $19575.97T in 2025 to $22992.82T in 2030; the average estimate for 2030 earnings per share is $3.35; with published estimates ranging from $3.23 to $3.46; 10 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

Measure	Value
Current priceWhat the share trades at now.	$23.69
Consensus targetThe average of the price targets analysts have published.	$23.67
Median targetThe middle target, less affected by a single outlier.	$24.50
Highest targetThe most optimistic published target.	$25.80
Lowest targetThe most pessimistic published target.	$19.90
Difference from priceHow far the consensus target sits from today’s price.	-0.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2025	$19109.06T	$19575.97T	$20086.12T	10
2026	$19186.34T	$19712.24T	$20238.13T	9
2027	$19959.79T	$20371.06T	$20782.33T	9
2028	$20577.95T	$21129.66T	$21685.93T	3
2029	$21351.73T	$21924.18T	$22501.36T	4
2030	$22392.47T	$22992.82T	$23598.14T	4

Earnings per share forecast

Year	Low	Average	High	Analysts
2025	$1.77	$1.94	$2.08	10
2026	$1.99	$2.06	$2.20	9
2027	$1.89	$2.16	$2.47	9
2028	$2.39	$2.48	$2.56	3
2029	$2.88	$2.98	$3.08	4
2030	$3.23	$3.35	$3.46	4

Fresenius Medical Care AG & Co. KGaA (FMS) forecast — frequently asked questions

What is the analyst price target for Fresenius Medical Care AG & Co. KGaA?

Analysts covering Fresenius Medical Care AG & Co. KGaA (FMS) have a consensus price target of $23.67, 0.1% below the current price of $23.69. Published targets range from $19.90 to $25.80. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Fresenius Medical Care AG & Co. KGaA's earnings?

The average analyst estimate for Fresenius Medical Care AG & Co. KGaA (FMS) earnings per share in 2030 is 3.35, with individual estimates between 3.23 and 3.46.

How much revenue is Fresenius Medical Care AG & Co. KGaA expected to make?

Analysts forecast Fresenius Medical Care AG & Co. KGaA (FMS) revenue of $22992.82T in 2030, based on 4 published estimates.

How many analysts cover FMS?

10 analysts contribute estimates for Fresenius Medical Care AG & Co. KGaA (FMS). Thin coverage makes an average less reliable.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks NYSE High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.